Immunogenicity of a multi-epitope DNA vaccine against hantavirus

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 2, 2012, Pages 198-205

  Zhao, Chen ^a,b   Sun, Ying ^a,b   Zhao, Yujie ^a,b   Wang, Si ^a,b   Yu, Tongtong ^a,b   Du, Feng ^a,b   Yang, X Frank ^b   Luo, Enjie ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemical gene synthesis; Glycoprotein; Hantavirus; HTNV; Multi epitope DNA vaccine; PUUV; SEOV

Indexed keywords

DNA VACCINE; ENVELOPE PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; PROTEIN TYROSINE PHOSPHATASE SHP;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CELLULAR IMMUNITY; CONTROLLED STUDY; EPITOPE MAPPING; HANTAVIRUS; HANTAVIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PUUMALA VIRUS; PUUMALA VIRUS INFECTION; SEOUL VIRUS; SEOUL VIRUS INFECTION; T LYMPHOCYTE; VIRUS MUTATION;

EID: 84863289539     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.8.2.18389     Document Type: Article

References (34)

1. Huiskonen JT, Hepojoki J, Laurinmaki P, Vaheri A, Lankinen H, Butcher SJ, et al. Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol 2010; 84:4889-97; PMID: 20219926; http://dx.doi.org/10.1128/JVI.00057-10
2. Schmaljohn C. Vaccines for hantaviruses. Vaccine 2009; 27(Suppl 4):D61-4; PMID:19837289; http:// dx.doi.org/10.1016/j.vaccine.2009.07.096
3. Khan AS, Gaviria M, Rollin PE, Hlady WG, Ksiazek TG, Armstrong LR, et al. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med 1996; 100:46-8; PMID:8579086; http://dx.doi.org/10.1016/S0002-9343(96)90010-8
4. Papa A, Bojovic B, Antoniadis A. Hantaviruses in Serbia and Montenegro. Emerg Infect Dis 2006; 12:1015-8; PMID:16707066
5. Tang LH, Zhang QF, Xiu MH, Gu GW, Bo S, Yang XD, et al. [Identification of a new Puumala hantavirus subtype in rodents from China]. Bing Du Xue Bao 2007; 23:320-5; PMID:17894236
6. Li C, Liu F, Liang M, Zhang Q, Wang X, Wang T, et al. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Vaccine 2010; 28:4294-300; PMID:20433802; http://dx.doi.org/10.1016/j. vaccine.2010.04.025
7. Luo W, Zhang F, Yan Y, Wu X, Liu Y, Bai W, et al. Immunological properties of a fusion protein containing nucleocapsid protein and glycoprotein Gn of hantaanvirus. Acta Virol 2008; 52:243-9; PMID:19143481
8. Yuan Z, Zhang X, Zhang S, Liu Y, Gao S, Zhang F, et al. Development of recombinant canine adenovirus type-2 expressing the Gn glycoprotein of Seoul virus. Biologicals 2008; 36:162-7; PMID:18249007; http://dx.doi.org/10.1016/j. biologicals.2007.10.003
9. Terajima M, Van Epps HL, Li D, Leporati AM, Juhlin SE, Mustonen J, et al. Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Res 2002; 84:67-77; PMID:11900840; http://dx.doi.org/10.1016/S0168-1702(01)00416-6
10. Tian L, Wang HN, Lu D, Zhang YF, Wang T, Kang RM. The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens. Biochem Biophys Res Commun 2008; 377:221-5; PMID:18840402; http://dx.doi.org/10.1016/j.bbrc. 2008.09.125
11. Hooper JW, Custer DM, Thompson E, Schmaljohn CS. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J Virol 2001; 75:8469-77; PMID:11507192; http://dx.doi.org/10.1128/JVI.75.18.8469- 8477.2001
12. Xiong AS, Peng RH, Zhuang J, Gao F, Li Y, Cheng ZM, et al. Chemical gene synthesis: strategies, softwares, error corrections, and applications. FEMS Microbiol Rev 2008; 32:522-40; PMID:18393987; http://dx.doi.org/10.1111/j.1574- 6976.2008.00109.x
13. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 1978; 137:298-308; PMID:24670; http://dx.doi.org/10.1093/infdis/137.3.298
14. Kitamura T, Morita C, Komatsu T, Sugiyama K, Arikawa J, Shiga S, et al. Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system. Jpn J Med Sci Biol 1983; 36:17-25; PMID:6134854
15. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 2000; 74:4839-52; PMID:10775623; http://dx.doi.org/10.1128/JVI.74.10.4839-4852.2000
16. Lee MS, Hseu YC, Lai GH, Chang WT, Chen HJ, Huang CH, et al. High yield expression in a recombinant E. coli of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development.Microb Cell Fact 2011; 10:56; PMID:21781331; http://dx.doi.org/10.1186/1475-2859-10-56
17. De Groot AS, McMurry J, Marcon L, Franco J, Rivera D, Kutzler M, et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 2005; 23:2121-31; PMID:15755582; http://dx.doi.org/10.1016/j.vaccine.2005.01.059
18. Suhrbier A. Multi-epitope DNA vaccines. Immunol Cell Biol 1997; 75:402-8; PMID:9315485; http://dx.doi.org/10.1038/icb.1997.63
19. Becker MM, Graham RL, Donaldson EF, Rockx B, Sims AC, Sheahan T, et al. Synthetic recombinant bat SARSlike coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci USA 2008; 105:19944-9; PMID: 19036930; http://dx.doi.org/10.1073/pnas.0808116105
20. Chen MW, Cheng TJ, Huang Y, Jan JT, Ma SH, Yu AL, et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci USA 2008; 105:13538-43; PMID:18765801; http://dx.doi.org/10.1073/pnas.0806901105
21. Burbelo PD, Ching KH, Han BL, Klimavicz CM, Iadarola MJ. Synthetic biology for translational research. Am J Transl Res 2010; 2:381-9; PMID:20733948
22. Yadava A, Sattabongkot J, Washington MA, Ware LA, Majam V, Zheng H, et al. A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites. Infect Immun 2007; 75:1177-85; PMID:17158893; http://dx.doi.org/10. 1128/IAI.01667-06
23. Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet 2008; 9:776-88; PMID: 18781156; http://dx.doi.org/10.1038/nrg2432
24. Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, et al. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J Am Vet Med Assoc 2005; 226:240-5; PMID:15706975; http://dx.doi.org/10.2460/javma.2005.226.240
25. Bergman PJ, Camps-Palau MA, McKnight JA, Leibman NF, Craft DM, Leung C, et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 2006; 24:4582-5; PMID:16188351; http://dx.doi.org/10.1016/j.vaccine.2005.08.027
26. Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 2008; 26:440-8; PMID:18082294; http://dx.doi.org/10.1016/j.vaccine.2007.10.041
27. Bharadwaj M, Lyons CR, Wortman IA, Hjelle B. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 1999; 17:2836-43; PMID: 10438054; http://dx.doi.org/10. 1016/S0264-410X(99)00096-1
28. Collisson EW, Pei J, Dzielawa J, Seo SH. Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry. Dev Comp Immunol 2000; 24:187-200; PMID:10717287; http://dx.doi.org/10.1016/S0145- 305X(99)00072-5
29. Thompson G, Mohammed H, Bauman B, Naqi S. Systemic and local antibody responses to infectious bronchitis virus in chickens inoculated with infectious bursal disease virus and control chickens. Avian Dis 1997; 41:519-27; PMID:9356695; http://dx.doi.org/10.2307/1592140
30. Viola JP, Rao A. Molecular regulation of cytokine gene expression during the immune response. J Clin Immunol 1999; 19:98-108; PMID:10226884; http://dx.doi.org/10.1023/A:1020502516196
31. Koshkina NV, Agoulnik IY, Melton SL, Densmore CL, Knight V. Biodistribution and pharmacokinetics of aerosol and intravenously administered DNApolyethyleneimine complexes: optimization of pulmonary delivery and retention. Mol Ther 2003; 8:249-54; PMID:12907147; http://dx.doi.org/10.1016/ S1525-0016(03)00177-1
32. Tuomela M, Malm M, Wallen M, Stanescu I, Krohn K, Peterson P. Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method. Vaccine 2005; 23:890-6; PMID:15603889; http://dx.doi.org/10.1016/j.vaccine.2004.08.004
33. Cichutek K. DNA vaccines: development, standardization and regulation. Intervirology 2000; 43:331-8; PMID: 11251389; http://dx.doi.org/10.1159/ 000054001
34. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals. World Health Organ Tech Rep Ser 1987; 747:1-29; PMID:3107222